These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27760780)

  • 21. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.
    Thomas MG; Redhead K; Lambert HP
    J Infect Dis; 1989 Feb; 159(2):211-8. PubMed ID: 2536779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.
    Eby JC; Gray MC; Warfel JM; Paddock CD; Jones TF; Day SR; Bowden J; Poulter MD; Donato GM; Merkel TJ; Hewlett EL
    Infect Immun; 2013 May; 81(5):1390-8. PubMed ID: 23429530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract.
    Carbonetti NH; Artamonova GV; Andreasen C; Bushar N
    Infect Immun; 2005 May; 73(5):2698-703. PubMed ID: 15845471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.
    Arciniega JL; Hewlett EL; Edwards KM; Burns DL
    FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel IgM-capture enzyme-linked immunosorbent assay using recombinant Vag8 fusion protein for the accurate and early diagnosis of Bordetella pertussis infection.
    Otsuka N; Gotoh K; Nishimura N; Ozaki T; Nakamura Y; Haga K; Yamazaki M; Gondaira F; Okada K; Miyaji Y; Toyoizumi-Ajisaka H; Shibayama K; Arakawa Y; Kamachi K
    Microbiol Immunol; 2016 May; 60(5):326-33. PubMed ID: 26996337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serodiagnosis of whooping cough in Belgium: results of the National Reference Centre for Bordetella pertussis anno 2013.
    Duterme S; Vanhoof R; Vanderpas J; Pierard D; Huygen K
    Acta Clin Belg; 2016 Apr; 71(2):86-91. PubMed ID: 27075799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
    Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
    APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxin-neutralizing antibodies in patients with pertussis, as determined by an assay using Chinese hamster ovary cells.
    Trollfors B; Krantz I; Sigurs N; Taranger J; Zackrisson G; Roberson R
    J Infect Dis; 1988 Nov; 158(5):991-5. PubMed ID: 3183431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin.
    Wang X; Stapleton JA; Klesmith JR; Hewlett EL; Whitehead TA; Maynard JA
    Biochemistry; 2017 Mar; 56(9):1324-1336. PubMed ID: 28177609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
    Calver GA; Burton WW; Gardell CY
    Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum IgA antibody to Bordetella pertussis as an indicator of infection.
    Nagel J; Poot-Scholtens EJ
    J Med Microbiol; 1983 Nov; 16(4):417-26. PubMed ID: 6315942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population.
    Lau RC
    N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.
    Skopova K; Tomalova B; Kanchev I; Rossmann P; Svedova M; Adkins I; Bibova I; Tomala J; Masin J; Guiso N; Osicka R; Sedlacek R; Kovar M; Sebo P
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.
    Torzsa P; Devadiga R; Tafalla M
    BMC Infect Dis; 2017 Apr; 17(1):242. PubMed ID: 28376739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding.
    Quinello C; Quintilio W; Carneiro-Sampaio M; Palmeira P
    Scand J Immunol; 2010 Jul; 72(1):66-73. PubMed ID: 20591078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.